InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Yankton Kevin Bruce, Directeur Comptable. Insider active across 1 company, notably Twist Bioscience Corp. Cumulatively, 8 reports have been recorded. History available since 16 November 2021. The latest transaction was disclosed on 17 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations8 total
235 shares@ US$33.910.0004% mcap36.1% of flowCommon StockSEC:0001214659-22-007224:0
67 shares@ US$52.910.0002% mcap15.3% of flowCommon StockSEC:0001214659-22-004864:0
75 shares@ US$77.390.0003% mcap100.0% of flowCommon StockSEC:0001214659-22-002361
75 shares@ US$77.390.0003% mcap24.3% of flowCommon StockSEC:0001214659-22-002361:0
3,448 shares0Common StockSEC:0001214659-21-013760
3,448 shares0Common StockSEC:0001214659-21-013760:0
1,600 shares0Common StockSEC:0001214659-21-012407
1,600 shares0Common StockSEC:0001214659-21-012407:0
8 of 8 declarations
About Yankton Kevin Bruce
Kevin Bruce Yankton is the Chief Accounting Officer at Twist Bioscience Corp. He oversees the company's accounting operations, ensuring the accuracy and compliance of financial reporting. His role is essential for financial management and operational transparency.
